Tg Therapeutics (TGTX) EBITDA (2009 - 2026)
Tg Therapeutics' EBITDA was $21.73 million in Q2 2026, down 37.7% from $34.86 million a year earlier and down 37.6% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tg Therapeutics' EBITDA was $136.45 million through Jun 30, 2026, up 58.9% year-over-year; for FY2025, it came in at $123.38 million, up 193.8% from FY2024.
- In earlier years, EBITDA was $42 million in FY2024 (+101.5%), $20.84 million in FY2023, -$217.8 million in FY2022 and -$344.28 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2025.
- Compared with a year earlier, EBITDA was higher in four of the last six quarters, with growth averaging 112.7%.
- Per Business Quant data, TGTX's EBITDA in the three quarters before Q2 2026 was $34.83 million (Q1 2026), $50.52 million (Q4 2025) and $29.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Tg Therapeutics | 9.71 Bn | 8.96 Bn | 217.86 Mn | 86.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 86.27 Mn |
| Jun 30, 2026 | 22.00 Mn |
| Mar 31, 2026 | 35.18 Mn |
| Dec 31, 2025 | 50.87 Mn |
| Sep 30, 2025 | 29.73 Mn |
| Jun 30, 2025 | 35.21 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 30.32 Mn |
| Sep 30, 2024 | 12.91 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | -8.55 Mn |
| Dec 31, 2023 | -11.73 Mn |
| Sep 30, 2023 | 115.55 Mn |
| Jun 30, 2023 | -43.95 Mn |
| Mar 31, 2023 | -36.41 Mn |
| Dec 31, 2022 | -76.95 Mn |
| Sep 30, 2022 | -34.37 Mn |
| Jun 30, 2022 | -38.35 Mn |
| Mar 31, 2022 | -66.28 Mn |
| Dec 31, 2021 | -92.43 Mn |
API Access
Tg Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();